110 related articles for article (PubMed ID: 40904)
1. Oral contraception, mechanical contraception, and carbohydrate and lipid metabolism: a two-year study.
Pribicevic V; Skrabalo Z; Lipovac V; Trenc S; Zadjelovic J; Rajkovic Z
Int J Fertil; 1979; 24(2):114-9. PubMed ID: 40904
[TBL] [Abstract][Full Text] [Related]
2. Prospective carbohydrate metabolism studies in women using a low-estrogen oral contraceptive for one year.
Spellacy WN; Birk SA; Buggie J; Buhi WC
J Reprod Med; 1981 Jun; 26(6):295-8. PubMed ID: 7019435
[TBL] [Abstract][Full Text] [Related]
3. [Influence of progestins on adverse effects of oral contraceptives].
Wynn V
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
[TBL] [Abstract][Full Text] [Related]
4. A 1-year randomized study to evaluate the effects of a dose reduction in oral contraceptives on lipids and carbohydrate metabolism: 20 microg ethinyl estradiol combined with 100 microg levonorgestrel.
Skouby SO; Endrikat J; Düsterberg B; Schmidt W; Gerlinger C; Wessel J; Goldstein H; Jespersen J
Contraception; 2005 Feb; 71(2):111-7. PubMed ID: 15707560
[TBL] [Abstract][Full Text] [Related]
5. The effect of sequential oral contraceptive pill (Fysioquens) administration on carbohydrate and lipid metabolism.
Vähäpassi J; Pyörälä T
Ann Chir Gynaecol; 1979; 68(2):75-81. PubMed ID: 507744
[TBL] [Abstract][Full Text] [Related]
6. Long-term profile of a new progestin.
Lippman J
Int J Fertil; 1992; 37 Suppl 4():218-22. PubMed ID: 1362189
[TBL] [Abstract][Full Text] [Related]
7. The effect of low-oestrogen combined pill, progestogen-only pill and medroxyprogesterone acetate on oral glucose tolerance test.
Kamau RK; Maina FW; Kigondu C; Mati JK
East Afr Med J; 1990 Aug; 67(8):550-5. PubMed ID: 2148146
[TBL] [Abstract][Full Text] [Related]
8. [Hormonal contraception with ethinylestradiol and gestoden. The effects on glucose tolerance and lipid metabolism].
Petersen KR; Skouby SO; Dreisler A; Kühl C
Ugeskr Laeger; 1987 Jun; 149(24):1614-6. PubMed ID: 3111056
[TBL] [Abstract][Full Text] [Related]
9. [Comparative studies on oral glucose tolerance and serum lipids under the influence of a new oral contraceptive (SH B 209 AB: 2 mg cyproterone acetate + 0.05 mg ethinyl estradiol), the combination D-norgestrel/ethinyl estradiol and in a control group (author's transl)].
Schillinger E; Gerloff C; Wellershoff S; Wendt H; Lachnit-Fixson U
Arzneimittelforschung; 1976; 26(12):2242-5. PubMed ID: 1037282
[TBL] [Abstract][Full Text] [Related]
10. Effect of low-dose oral contraceptives on carbohydrate and lipid metabolism in women with recent gestational diabetes: results of a controlled, randomized, prospective study.
Kjos SL; Shoupe D; Douyan S; Friedman RL; Bernstein GS; Mestman JH; Mishell DR
Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 1):1822-7. PubMed ID: 2256489
[TBL] [Abstract][Full Text] [Related]
11. Glucose and insulin levels after six months of treatment with a triphasic oral contraceptive containing ethinyl estradiol and norethindrone.
Spellacy WN; Ellingson AB; Tsibris JC
J Reprod Med; 1989 Aug; 34(8):540-2. PubMed ID: 2681750
[TBL] [Abstract][Full Text] [Related]
12. Glucose, cholesterol and triglyceride levels in "normal" women during one year of use of an inert intrauterine device.
Spellacy WN; Buhi WC; Birk SA
J Reprod Med; 1981 May; 26(5):247-9. PubMed ID: 7252937
[TBL] [Abstract][Full Text] [Related]
13. [Modification of serum lipids and glucose tolerance by sequential Ovosiston and Minisiston].
Vesper VB; Feustel S
Zentralbl Gynakol; 1988; 110(4):241-5. PubMed ID: 2453102
[TBL] [Abstract][Full Text] [Related]
14. Low dosage oral contraception in women with previous gestational diabetes.
Skouby SO; Mølsted-Pedersen L; Kühl C
Obstet Gynecol; 1982 Mar; 59(3):325-8. PubMed ID: 6804901
[TBL] [Abstract][Full Text] [Related]
15. [Metabolic risks of oral contraception].
Monier L
Rev Int Pediatr; 1988 Feb; (178):64-5. PubMed ID: 12282576
[TBL] [Abstract][Full Text] [Related]
16. Metabolic effects of a combination of dl-norgestrel and ethinylestradiol in humans.
Gerhards E; Lachnit U; Gaude R; Schillinger E
Arzneimittelforschung; 1973 Jun; 23(6):779-84. PubMed ID: 4740760
[No Abstract] [Full Text] [Related]
17. [Effect of the estrogen-progesterone combination preparations gravistat and Minisiston on carbohydrate metabolism].
Albus C; Männchen E
Zentralbl Gynakol; 1987; 109(8):521-6. PubMed ID: 3111130
[TBL] [Abstract][Full Text] [Related]
18. Metabolic effects of oral contraceptives containing 30 micrograms and 50 micrograms of oestrogen.
Nash AL; Cornish EJ; Hain R
Med J Aust; 1979 Sep; 2(6):277-81. PubMed ID: 230411
[TBL] [Abstract][Full Text] [Related]
19. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
Petersen KR
Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
[TBL] [Abstract][Full Text] [Related]
20. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
Teichmann A
Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
